Highlights and recent developments in airway diseases in EAACI journals (2018) - Université de Montpellier Accéder directement au contenu
Article Dans Une Revue Allergy Année : 2019

Highlights and recent developments in airway diseases in EAACI journals (2018)

Résumé

The European Academy of Allergy and Clinical Immunology (EAACI) supports three journals: Allergy, Pediatric Allergy and Immunology, and Clinical and Translational Allergy. EAACI's major goals include supporting the promotion of health, in which the prevention of allergy and asthma plays a critical role, and disseminating the knowledge of allergic disease to all stakeholders. In 2018, the remarkable progress in the identification of basic mechanisms of allergic and respiratory diseases as well as the translation of these findings into clinical practice were observed. Last year's highlights include publication of EAACI guidelines for allergen immunotherapy, many EAACI Position Papers covering important aspects for the specialty, better understanding of molecular and cellular mechanisms, identification of biomarkers for disease prediction and progress monitoring, novel prevention and intervention studies, elucidation of mechanisms of multimorbidities, introduction of new drugs to the clinics, recently completed phase three clinical studies, and publication of a large number of allergen immunotherapy studies and meta-analyses.
Fichier principal
Vignette du fichier
Allergy - 2019 - Bousquet - Highlights and recent developments in airway diseases in EAACI journals 2018.pdf (938.94 Ko) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte
Licence : CC BY - Paternité

Dates et versions

hal-02556870 , version 1 (07-06-2023)

Identifiants

Citer

Jean Bousquet, Cezmi Akdis, Clive Grattan, Philippe Eigenmann, Karin Hoffmann‐sommergruber, et al.. Highlights and recent developments in airway diseases in EAACI journals (2018). Allergy, 2019, 74 (12), pp.2329-2341. ⟨10.1111/all.14068⟩. ⟨hal-02556870⟩
33 Consultations
57 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More